Millions of people are diagnosed with Alzheimer's disease each year, comprising 60% to 70% of dementia cases worldwide. While cognitive impairment and structural brain changes are indicative of ...

Rituximab pre-conditioning in a phase I study of CARv3-TEAM-E for recurrent glioblastoma (GBM): The INCIPIENT trial.

In a new open-access study that I published with my late colleague Kostya Trachenko from Queen Mary University of London, I propose a surprisingly simple nonlinear mathematical equation that unifies ...